Rossari Biotech
Rossari Biotech Share Price Chart
Rossari Biotech last traded at ₹427.65 (2026-10-13). Over the past month the stock moved -5.3%, three months the stock moved -21.4%, year the stock moved -36.6%. Its closing range over 52 weeks is ₹398.00 – ₹671.30, with the latest close 36.3% below the high.
Closing prices up to 2026-10-13.
About Rossari Biotech
Rossari Biotech was started in 2003. They are among the largest manufacturers of textile specialty chemicals in India. [1]
Product Segments The company is one of India’s leading specialty chemicals manufacturer offering 4,280+ products across 3 verticals: [1]
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Rossari Biotech reported sales of ₹697.00 crore (+28.1%) and net profit of ₹35.00 crore (+2.9%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 697.00 | 81.00 | 12.00 | 35.00 | 6.34 |
| Mar 2026 | 685.00 | 77.00 | 11.00 | 46.00 | 8.30 |
| Dec 2025 | 582.00 | 69.00 | 12.00 | 33.00 | 5.92 |
| Sep 2025 | 586.00 | 72.00 | 12.00 | 37.00 | 6.66 |
| Jun 2025 | 544.00 | 68.00 | 12.00 | 34.00 | 6.07 |
| Mar 2025 | 580.00 | 69.00 | 12.00 | 34.00 | 6.22 |
| Dec 2024 | 513.00 | 65.00 | 13.00 | 32.00 | 5.73 |
| Sep 2024 | 498.00 | 66.00 | 13.00 | 35.00 | 6.39 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +3.1% | +10.6% | +22.6% | +11.0% | +17.7% | +13.5% | +18.1% | +28.1% |
| Operating profit growth | +3.1% | +1.6% | +7.8% | +4.6% | +9.1% | +6.2% | +11.6% | +19.1% |
| Net profit growth | +6.1% | -5.9% | +0.0% | -2.9% | +5.7% | +3.1% | +35.3% | +2.9% |
| EPS growth | +7.0% | -8.0% | +0.6% | -4.0% | +4.2% | +3.3% | +33.4% | +4.4% |
| OPM % | 13.0% | 13.0% | 12.0% | 12.0% | 12.0% | 12.0% | 11.0% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Rossari Biotech reported sales of ₹2,396.00 crore (+15.2%) and net profit of ₹149.00 crore (+9.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,396 | 286.00 | 12.00 | 149.00 | 26.94 |
| Mar 2025 | 2,080 | 265.00 | 13.00 | 136.00 | 24.63 |
| Mar 2024 | 1,831 | 250.00 | 14.00 | 131.00 | 23.66 |
| Mar 2023 | 1,656 | 223.00 | 13.00 | 107.00 | 19.45 |
| Mar 2022 | 1,483 | 184.00 | 12.00 | 98.00 | 17.74 |
| Mar 2021 | 709.00 | 124.00 | 17.00 | 80.00 | 15.45 |
| Mar 2020 | 600.00 | 105.00 | 17.00 | 65.00 | 12.86 |
| Mar 2019 | 516.00 | 78.00 | 15.00 | 46.00 | 103.82 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +16.3% | +18.2% | +109.2% | +11.7% | +10.6% | +13.6% | +15.2% |
| Operating profit growth | +34.6% | +18.1% | +48.4% | +21.2% | +12.1% | +6.0% | +7.9% |
| Net profit growth | +41.3% | +23.1% | +22.5% | +9.2% | +22.4% | +3.8% | +9.6% |
| EPS growth | -87.6% | +20.1% | +14.8% | +9.6% | +21.6% | +4.1% | +9.4% |
| OPM % | 17.0% | 17.0% | 12.0% | 13.0% | 14.0% | 13.0% | 12.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Rossari Biotech.
Get Free AI Stock Analysis FREE →Latest News
-
Rossari Biotech registers PAT of Rs 35 crore in Q1 FY27 - Business Standard
-
Rossari Biotech reports Profit after tax of Rs 342.66 Mln, in the June 2026 quarter
-
Rossari Biotech consolidated net profit rises 4.46% in the June 2026 quarter - Business Standard
-
Rossari Biotech unit sets up Thailand facility with 5000 MTPA capacity - scanx.trade
-
Rossari Consolidated March 2026 Net Sales at Rs 684.86 crore, up 18.17% Y-o-Y - Moneycontrol.com
-
Rossari Consolidated March 2026 Net Sales at Rs 684.86 crore, up 18.17% Y-o-Y - Moneycontrol.com
-
Rossari Consolidated March 2026 Net Sales at Rs 684.86 crore, up 18.17% Y-o-Y - Moneycontrol.com
-
Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarter - Business Standard
-
Rossari Biotech sets up new R&D facility at Navi Mumbai - Business Standard
-
Rossari Biotech consolidated net profit rises 33.48% in the March 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of Rossari Biotech today?
Rossari Biotech shares were last quoted at ₹427.65 (+4.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Rossari Biotech?
Rossari Biotech has a price-to-earnings (P/E) ratio of 16.36 and a price-to-book (P/B) ratio of 1.80. The industry P/E is 60.35.
What is the 52-week high and low of Rossari Biotech?
The 52-week high of Rossari Biotech is ₹690.90 and the 52-week low is ₹372.90.
What is the market cap of Rossari Biotech?
The market capitalisation of Rossari Biotech is about ₹2,465.87 crore.
How did Rossari Biotech perform in its latest quarterly results?
In the latest quarter (Jun 2026), Rossari Biotech reported sales of ₹697.00 crore (+28.1%) and net profit of ₹35.00 crore (+2.9%), compared with the same quarter last year.
Is Rossari Biotech a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Rossari Biotech has a 3-year ROE of 12.00%, 3-year profit growth of 8.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Rossari Biotech?
Promoters hold about 68.14% of Rossari Biotech.
Which sector does Rossari Biotech belong to?
Rossari Biotech belongs to the Speciality Chemicals sector.